HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feinberg, H. Articles by LeBreton, G. Search for Related Content PubMed PubMed Citation Articles by Feinberg, H. Articles by LeBreton, G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 84, 815-822, Copyright © 1982 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Platelet deposition after surgically induced myocardial ischemia. An etiologic factor for reperfusion injury

H Feinberg, DS Rosenbaum, S Levitsky, NA Silverman, J Kohler and G LeBreton

Despite meticulous adherence to presently known principles of myocardial preservation, reperfusion after aortic cross-clamping results in a unique injury manifested by decreasing high-energy phosphate levels and increased coronary resistance. We hypothesize that platelet deposition into the coronary microvasculature is a major factor in reperfusion injury. To differentiate platelet deposition due to subendocardial hemorrhage from deposition due to vascular entrapment, we infused 111In-labeled platelets together with 51Cr- labeled erythrocytes into 15 dogs that were on normothermic bypass and subjected to 60 minutes of global ischemia followed by 30 minutes of reperfusion. Platelet deposition is indicated only when the proportion of platelets to erythrocytes in tissue exceeds that measured by peripheral blood. Myocardial biopsy specimens were obtained after 10 minutes of bypass, 120 minutes of continuous bypass (Group I), and at the end of reperfusion after global ischemia (Group II). In five dogs (Group III), dipyridamole (1 mg/kg), an antiplatelet activation agent, was administered in the preischemic period. Platelet deposition was expressed as the number of radioactive-labeled platelets deposited per gram of tissue. Bypass for 120 minutes resulted in only a minimal increase in platelet deposition. However, normothermic ischemia followed by reperfusion resulted in over a twofold increase in platelet deposition compared to controls. Pretreatment with dipyridamole appeared to avoid platelet deposition. These data indicate that platelet deposition in the coronary microcirculation following surgically induced myocardial ischemia may be associated with reperfusion injury and that antiplatelet drugs after this sequence.

This article has been cited by other articles:

				K Shimada, Y Sakanoue, Y Kobayashi, S Ehara, M Hirose, Y Nakamura, D Fukuda, H Yamagishi, M Yoshiyama, K Takeuchi, et al. Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction Heart, January 1, 2003; 89(1): 71 - 76. [Abstract] [Full Text] [PDF]

				J. A Barrabes, D. Garcia-Dorado, B. Soriano, J. Solares, Y. Puigfel, L. Trobo, A. Garcia-Lafuente, and J. Soler-Soler Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization Cardiovasc Res, August 1, 2000; 47(2): 265 - 273. [Abstract] [Full Text] [PDF]

				B. Yang, P. Mehta, and J. L. Mehta Platelet-Mediated Cardioprotective Effect Against Ischemia-Reperfusion Injury in Isolated Rat Hearts: Role of Platelet Number and Contribution of Supernatant of Aggregated Platelets Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(1): 23 - 28. [Abstract] [PDF]

				Y. J. Gu, A. J. deVries, P. W. Boonstra, and W. van Oeveren LEUKOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION AND REDUCED INFLAMMATORY RESPONSE AFTER CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 494 - 500. [Abstract] [Full Text]

				S. M. Martin, H. Laks, D. C. Drinkwater, D. G. Stein, E. R. Capouya, J. M. Pearl, S. W. Barthel, P. Chang, E. Kaczer, and S. Bhuta Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia Ann. Thorac. Surg., April 1, 1993; 55(4): 954 - 960. [Abstract] [PDF]

				E. S. Yee and W.-R. Hsieh Ischemia-Activated Platelets in Normal and in Naturally Occurring Hypertrophied Myocardium Vascular and Endovascular Surgery, April 1, 1992; 26(3): 186 - 192. [Abstract] [PDF]

				P. J. Pearson, P. J. Lin, and H. V. Schaff Production of endothelium-derived contracting factor is enhanced after coronary reperfusion Ann. Thorac. Surg., May 1, 1991; 51(5): 788 - 793. [Abstract] [PDF]

				H. Matsuda, Y. Sawa, S. Kuki, F. Nomura, M. Ohtani, H. Takami, R. Shirakura, S. Nakano, and Y. Kawashima Evaluation of prostacyclin analogue OP-41483 as an adjunct to crystalloid cardioplegia in infants and children Ann. Thorac. Surg., August 1, 1989; 48(2): 242 - 246. [Abstract] [PDF]

				T. Aherne, E. S. Yee, G. Gollin, and P. A. Ebert Does Prostacyclin (PGI2) Cardioplegic Infusion Improve Myocardial Protection after Ischemic Arrest? Ann. Thorac. Surg., October 1, 1985; 40(4): 368 - 373. [Abstract] [PDF]